PALATINE, Ill., April 30, 2008 (PRIME NEWSWIRE) -- Acura Pharmaceuticals, Inc. (Nasdaq:ACUR) reported net income of $7.4 million, or $0.15 per diluted share for the quarter ending March 31, 2008 compared to a net loss of $9.2 million, or $0.26 loss per diluted share for the same quarter in 2007.
